Literature DB >> 1623766

The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.

J P Orlowski1, L Wateska.   

Abstract

We examined the impact on physician prescribing patterns of pharmaceutical firms offering all-expenses-paid trips to popular sunbelt vacation sites to attend symposia sponsored by a pharmaceutical company. The impact was assessed by tracking the pharmacy inventory usage reports for two drugs before and after the symposia. Both drugs were available only as intravenous preparations and could be used only on hospitalized patients. The usage patterns were tracked for 22 months preceding each symposium and for 17 months after each symposium. Ten physicians invited to each symposium were interviewed about the likelihood that such an enticement would affect their prescribing patterns. A significant increase in the prescribing pattern of both drugs occurred following the symposia. The usage of drug A increased from a mean of 81 +/- 44 units before the symposium to a mean of 272 +/- 117 after the symposium (p less than 0.001). The usage of drug B changed from 34 +/- 30 units before the symposium to 87 +/- 24 units (p less than 0.001) after the symposium. These changed prescribing patterns were also significantly different from the national usage patterns of the two drugs by hospitals with more than 500 beds and major medical centers over the same period of time. These alterations in prescribing patterns occurred even though the majority of physicians who attended the symposia believed that such enticements would not alter their prescribing patterns.

Entities:  

Keywords:  Cleveland Clinic Foundation; Empirical Approach; Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  1992        PMID: 1623766     DOI: 10.1378/chest.102.1.270

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  69 in total

1.  Do drug company promotions influence physician behavior?

Authors:  B Goodman
Journal:  West J Med       Date:  2001-04

2.  Guidelines for advertising on health web sites: who's guarding the Koop.

Authors:  M K Cho
Journal:  West J Med       Date:  2000-04

3.  Direct to consumer advertising of prescription drugs. An idea whose time should not come.

Authors:  J R Hoffman; M Wilkes
Journal:  BMJ       Date:  1999-05-15

4.  Of mugs, meals and more: the intricate relations between physicians and the medical industry.

Authors:  Stephan Sahm
Journal:  Med Health Care Philos       Date:  2013-05

5.  The relationship between physicians and the pharmaceutical industry: ethical problems with the every-day conflict of interest.

Authors:  Richard L Allman
Journal:  HEC Forum       Date:  2003-06

6.  The HEC and conflicts of interest in the health care environment.

Authors:  J P Orlowski
Journal:  HEC Forum       Date:  1994-01

7.  Effect of drug sample removal on prescribing in a family practice clinic.

Authors:  Daniel M Hartung; David Evans; Dean G Haxby; Dale F Kraemer; Gabriel Andeen; Lyle J Fagnan
Journal:  Ann Fam Med       Date:  2010 Sep-Oct       Impact factor: 5.166

8.  Norwegian medical students' attitudes towards the pharmaceutical industry.

Authors:  Dordi Lea; Olav Spigset; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2010-03-19       Impact factor: 2.953

9.  A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.

Authors:  Klaus Lieb; Simone Brandtönies
Journal:  Dtsch Arztebl Int       Date:  2010-06-04       Impact factor: 5.594

10.  Towards a balanced approach to identifying conflicts of interest faced by institutional review boards.

Authors:  Sharon Kaur; Sujata Balan
Journal:  Theor Med Bioeth       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.